Jianjun Yu

21.8k total citations · 5 hit papers
64 papers, 8.9k citations indexed

About

Jianjun Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jianjun Yu has authored 64 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Cancer Research and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jianjun Yu's work include Cancer Genomics and Diagnostics (12 papers), Prostate Cancer Treatment and Research (12 papers) and Cancer-related molecular mechanisms research (9 papers). Jianjun Yu is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Prostate Cancer Treatment and Research (12 papers) and Cancer-related molecular mechanisms research (9 papers). Jianjun Yu collaborates with scholars based in China, United States and Australia. Jianjun Yu's co-authors include Arul M. Chinnaiyan, Daniel R. Rhodes, Debashis Ghosh, Terrence R. Barrette, Nandan Deshpande, K. Shanker, Shanker Kalyana‐Sundaram, Prakash Kulkarni, Vasudeva Mahavisno and Scott A. Tomlins and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jianjun Yu

60 papers receiving 8.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform

2004 2.8k citations Daniel R. Rhodes, Jianjun Yu et al. Neoplasia profile →
Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles

2007 1.7k citations Daniel R. Rhodes, Jianjun Yu et al. Neoplasia profile →
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

2004 789 citations Daniel R. Rhodes, Jianjun Yu et al. profile →
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

2005 612 citations Sooryanarayana Varambally, Jianjun Yu et al. Cancer Cell profile →
Single‐cell RNA sequencing in cancer research

2021 234 citations Fang Xiong, Can Guo et al. profile →

Peers

Jianjun Yu

PRM

ONCOL

IMMUN

Cyril H. Benes United States

James Brugarolas United States

Carmen Behrens United States

Joanne Edwards United Kingdom

James J. Hsieh United States

Howard Colman United States

Mathew J. Garnett United Kingdom

Yichao Sun United States

Gideon Dresdner United States

Hui‐Kuan Lin United States

Cyril H. Benes United States

Jianjun Yu

7.4k ×1.2

2.5k ×0.9

2.9k ×1.2

PRM

4.0k ×2.1

ONCOL

804 ×0.8

IMMUN

Citations per year, relative to Jianjun Yu Jianjun Yu (= 1×) peers Cyril H. Benes

Countries citing papers authored by Jianjun Yu

Since Specialization

Citations

This map shows the geographic impact of Jianjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Yu more than expected).

Fields of papers citing papers by Jianjun Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Yu. The network helps show where Jianjun Yu may publish in the future.

Co-authorship network of co-authors of Jianjun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Yu. A scholar is included among the top collaborators of Jianjun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Yu. Jianjun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Ruizhi, Yanzhen Li, Min Liang, et al.. (2023). Stellate Ganglion Block Improves Postoperative Sleep Quality and Analgesia in Patients with Breast Cancer: A Randomized Controlled Trial. Pain and Therapy. 12(2). 491–503. 17 indexed citations

Shang, Shaobin, Fei Wang, Ruikang K. Wang, et al.. (2023). The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). e11–e11. 1 indexed citations

Zheng, Tiantian, Xiaoran Liu, Bin Shao, et al.. (2022). Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of Translational Medicine. 20(1). 211–211. 12 indexed citations

Bai, Han, Jianjun Yu, Shidong Jia, et al.. (2021). Prognostic Value of the TP53 Mutation Location in Metastatic Breast Cancer as Detected by Next-Generation Sequencing. Cancer Management and Research. Volume 13. 3303–3316. 8 indexed citations

Liu, Xiaoran, Andrew A. Davis, Feng Xie, et al.. (2021). Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China. Breast Cancer Research and Treatment. 190(2). 213–226. 5 indexed citations

Hauser, Christine, Patricia Bukczynska, Nicole Ng, et al.. (2021). Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer. Asia-Pacific Journal of Clinical Oncology. 17. 1 indexed citations

Xiong, Fang, Kunjie Zhu, Su Deng, et al.. (2021). AFAP1-AS1: a rising star among oncogenic long non-coding RNAs. Science China Life Sciences. 64(10). 1602–1611. 14 indexed citations

Kohli, Manish, Winston Tan, Tiantian Zheng, et al.. (2020). Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer. EBioMedicine. 54. 102728–102728. 89 indexed citations

Zhu, Kunjie, Yongzhen Mo, Jie Wang, et al.. (2020). Neutrophils: Accomplices in metastasis. Cancer Letters. 492. 11–20. 20 indexed citations

10.

Peng, Xiaowei, Peiguo Cao, Jingjing Li, et al.. (2015). MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel bothin vitroandin vivo. Cancer Biology & Therapy. 16(2). 261–267. 21 indexed citations

11.

Ding, Wenzhou, et al.. (2015). MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma. Oncology Letters. 11(2). 1081–1088. 11 indexed citations

12.

Chen, Yaoyu, Jinyun Chen, Jianjun Yu, et al.. (2014). Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition. Journal of Biological Chemistry. 289(27). 18914–18927. 12 indexed citations

13.

Chen, Hongli, et al.. (2010). Relationship Between Cell Wall Matter Content in Sichuan Flue-cured Tobacco and its Appearance and Sensory Quality. Tobacco Science & Technology.

14.

Laxman, Bharathi, David S. Morris, Jianjun Yu, et al.. (2008). A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer. Cancer Research. 68(3). 645–649. 303 indexed citations

15.

Mehra, Rohit, Scott A. Tomlins, Jianjun Yu, et al.. (2008). Characterization of TMPRSS2 -ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer. Cancer Research. 68(10). 3584–3590. 202 indexed citations

16.

Yu, Jianjun, Jindan Yu, Kevin E. Cordero, et al.. (2008). A Transcriptional Fingerprint of Estrogen in Human Breast Cancer Predicts Patient Survival. Neoplasia. 10(1). 79–IN34. 29 indexed citations

17.

Yu, Jindan, Jianjun Yu, Daniel R. Rhodes, et al.. (2007). A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome. Cancer Research. 67(22). 10657–10663. 251 indexed citations

18.

Yu, Jindan, Qi Cao, Rohit Mehra, et al.. (2007). Integrative Genomics Analysis Reveals Silencing of β-Adrenergic Signaling by Polycomb in Prostate Cancer. Cancer Cell. 12(5). 419–431. 181 indexed citations

19.

Thomas, Monzy, Zhigang Yu, Sooryanarayana Varambally, et al.. (2005). The Unfolded Protein Response Modulates Toxicity of the Expanded Glutamine Androgen Receptor. Journal of Biological Chemistry. 280(22). 21264–21271. 45 indexed citations

20.

Rhodes, Daniel R., Jianjun Yu, K. Shanker, et al.. (2004). ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform. Neoplasia. 6(1). 1–6. 2835 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact